Enanta Pharmaceuticals ENTA
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 15.77 | 127.43 | -0.42 | -11,253 | -12 | |
| 2025Q3 | 11.97 | 112.93 | -0.88 | -18,386 | -19 | |
| 2025Q2 | 7.56 | 113.76 | -0.85 | -18,893 | -18 | |
| 2025Q1 | 5.52 | 110.31 | -1.06 | -24,527 | -23 | |
| 2024Q4 | 5.75 | 113.49 | -1.05 | -23,543 | -22 | |
| 2024Q3 | 10.36 | 112.21 | -1.36 | -29,854 | -29 | |
| 2024Q2 | 12.97 | 116.85 | -1.06 | -24,185 | -23 | |
| 2024Q1 | 17.46 | 113.15 | -1.48 | -32,766 | -31 | |
| 2023Q4 | 9.41 | 114.05 | -1.58 | -34,886 | -33 | |
| 2023Q3 | 11.17 | 117.69 | -1.33 | -31,030 | -28 | |
| 2023Q2 | 21.40 | 111.77 | -1.86 | -36,713 | -39 | |
| 2023Q1 | 40.44 | 104.88 | -1.80 | -39,451 | -38 | |
| 2022Q4 | 46.52 | 103.42 | -1.39 | -30,013 | -29 | |
| 2022Q3 | 51.87 | 102.71 | -1.27 | -27,048 | -26 | |
| 2022Q2 | 47.27 | 101.22 | -1.53 | -32,540 | -32 | |
| 2022Q1 | 71.18 | 100.87 | -1.63 | -33,847 | -34 | |
| 2021Q4 | 74.78 | 100.86 | -1.48 | -30,409 | -30 | |
| 2021Q3 | 56.81 | 101.00 | -1.22 | -33,727 | -25 | |
| 2021Q2 | 44.01 | 101.31 | -1.19 | -33,847 | -24 | |
| 2021Q1 | 49.32 | 101.87 | -1.10 | -29,700 | -22 |